The association between inflammation and kynurenine pathway metabolites in electroconvulsive therapy for schizophrenia: Implications for clinical efficacy.
Brain Behav Immun
; 113: 1-11, 2023 10.
Article
in En
| MEDLINE
| ID: mdl-37353059
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Schizophrenia
/
Electroconvulsive Therapy
Type of study:
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Brain Behav Immun
Journal subject:
ALERGIA E IMUNOLOGIA
/
CEREBRO
/
PSICOFISIOLOGIA
Year:
2023
Type:
Article
Affiliation country:
China